CANCER IMMUNOTHERAPY

Details for Australian Patent Application No. 2003292405 (hide)

Owner THE UNIVERSITY OF BIRMINGHAM

Inventors YOUNG, Lawrence, Sterling; ADAMS, David, Harvey; IRVINE, Alistair, Simpson

Pub. Number AU-A-2003292405

PCT Number PCT/GB2003/0054

PCT Pub. Number WO2004/052392

Priority 0228900.7 11.12.02 GB

Filing date 10 December 2003

Wipo publication date 30 June 2004

International Classifications

A61K 039/002 Medicinal preparations containing antigens or antibodies - Protozoa antigens

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07K 014/82 Peptides having more than 20 amino acids - Translation products from oncogenes

Event Publications

8 April 2004 Complete Application Filed

  Priority application(s): 0228900.7 11.12.02 GB

5 August 2004 Application Open to Public Inspection

  Published as AU-A-2003292405

25 August 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003292406-SERINE PROTEASE

2003292404-GENETIC SUSCEPTIBILITY